Bayer Wants to Settle All Roundup-Related Cancer Claims for $8 BillionThe German company, which inherited Roundup from Monsanto, is facing 18,000 U.S. lawsuits over the weedkiller.
Adidas Boss Warns Currency War Will Hurt More Than Tariffs"There is no winner in a currency war," said CEO Kasper Rorsted.
Bayer Reports 5,000 More Roundup-Related Cancer Lawsuits“The jump in lawsuits is worrying,” an analyst said of the flood of litigation Bayer has inherited from Monsanto.
Bayer Commits $5.6 Billion to Glyphosate Alternatives Amid 13,000 Lawsuits Over the WeedkillerThe move is seen as an olive branch to critics of the Roundup weedkiller, which is accused of causing cancer.
Why Adidas Shares Are SoaringThe sports apparel maker is maintaining its half-decade hot streak.
Bayer Gets Temporary Relief from Its Monsanto-Roundup WoesThe company faces mounting lawsuits alleging that Monsanto's Roundup weedkiller is linked to cancer.
Roche Bids $4.8 Billion for U.S.-Based Gene Therapy Specialist SparkPurchasing Philadelphia-based Spark will help Roche to compete with Basel-based neighbor Novartis AG in developing the new area of medicine
1 - 7 of 7 results
1 - 7 of 7 results
